Evidence map›Paper›PMID 34707502›Full record

ArticleFrontiers in pharmacology2021

European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement.

Job Fm van Boven, Ioanna Tsiligianni, Ines Potočnjak, Jovan Mihajlović, Alexandra L Dima, Urska Nabergoj Makovec, Tamás Ágh, Prezmyslaw Kardas, Cristina Mihaela Ghiciuc, Guenka Petrova and 4 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Job Fm van BovenDepartment of Clinical Pharmacy and Pharmacology, Medication Adherence Expertise Center of the Northern Netherlands (MAECON), University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Ioanna TsiligianniDepartment of Social Medicine, School of Medicine, University of Crete, Rethymnon, Greece.
Ines PotočnjakInstitute for Clinical Medical Research and Education, University Hospital Centre Sisters of Charity, Zagreb, Croatia.
Jovan MihajlovićMihajlović Health Analytics, (MiHA), Novi Sad, Serbia.
Alexandra L DimaResearch on Healthcare Performance (RESHAPE), INSERM U1290, University Claude Bernard Lyon 1, Lyon, France.
Urska Nabergoj MakovecFaculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Tamás ÁghSyreon Research Institute, Budapest, Hungary.
Prezmyslaw KardasMedication Adherence Research Centre, Medical University of Lodz, Lodz, Poland.
Cristina Mihaela GhiciucDepartment of Morphofunctional Sciences II-Pharmacology, Clinical Pharmacology and Algesiology, School of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.
Guenka PetrovaDepartment of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
Noemi BittermanIndustrial Design, Technion, Israel Institute of Technology, Haifa, Israel.
Fatjona KamberiFaculty of Health, Research Center of Public Health, University of Vlore "Ismail Qemali", Vlore, Albania.
Josip CuligPharmacoepidemiology Department, Andrija Stampar Teaching Institute of Public Health, Zagreb, Croatia.
Björn WettermarkDepartment of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication non-adherence is associated with almost 200,000 deaths annually and €80-125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.

Indexed as

COST Action 19132drug therapyeHealthmedical technologiesmedication adherencemedication managementpersistence

Identifiers

PMID34707502
PMCPMC8544003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.